Prescribed Doses of CYP2D6-Metabolized Drugs and Hemodynamic Responses in Relation to CYP2D6 Genotype Among Older Patients Exposed to Polypharmacy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1969
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prescribed Doses of CYP2D6-Metabolized Drugs and Hemodynamic Responses in Relation to CYP2D6 Genotype Among Older Patients Exposed to Polypharmacy ; volume:37 ; number:6 ; day:29 ; month:4 ; year:2020 ; pages:425-433 ; date:6.2020
Drugs & aging ; 37, Heft 6 (29.4.2020), 425-433, 6.2020
- Creator
-
Romskaug, Rita
Wyller, Torgeir Bruun
Straand, Jørund
Kersten, Hege
Molden, Espen
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40266-020-00763-0
- URN
-
urn:nbn:de:101:1-2020081112003239187949
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Romskaug, Rita
- Wyller, Torgeir Bruun
- Straand, Jørund
- Kersten, Hege
- Molden, Espen
- SpringerLink (Online service)
Other Objects (12)
Bedeutung des CYP2D6-Genpolymorphismus für die Therapiesicherheit und Wirksamkeit von CYP2D6-abhängig metabolisierten Antidepressiva
Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivo
Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions
Allele Drop Out Conferred by a Frequent CYP2D6 Genetic Variation For Commonly Used CYP2D6*3 Genotyping Assays
Enantioselective metabolism of primaquine by human CYP2D6
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
The CYP2D6 animal model: how to induce autoimmune hepatitis in mice
CYP2D6-Phänotypisierung und Bestimmung des Dextromethorphanmetabolismus mittels Hochleistungsflüssigkeitschromatographie
Frequencies of CYP2D6 genetic polymorphisms in Arab populations
CYP2D6-Phänotypisierung und Bestimmung des Dextromethorphanmetabolismus mittels Hochleistungsflüssigkeitschromatographie
Molecular analysis of mechanisms leading to CYP2D6 intermediate and ultrarapid metabolizer phenotypes
Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites—a study in 839 patients with known CYP2D6 genotype
Bedeutung des CYP2D6-Genpolymorphismus für die Therapiesicherheit und Wirksamkeit von CYP2D6-abhängig metabolisierten Antidepressiva
Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivo
Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions
Allele Drop Out Conferred by a Frequent CYP2D6 Genetic Variation For Commonly Used CYP2D6*3 Genotyping Assays
Enantioselective metabolism of primaquine by human CYP2D6
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
The CYP2D6 animal model: how to induce autoimmune hepatitis in mice
CYP2D6-Phänotypisierung und Bestimmung des Dextromethorphanmetabolismus mittels Hochleistungsflüssigkeitschromatographie
Frequencies of CYP2D6 genetic polymorphisms in Arab populations
CYP2D6-Phänotypisierung und Bestimmung des Dextromethorphanmetabolismus mittels Hochleistungsflüssigkeitschromatographie
Molecular analysis of mechanisms leading to CYP2D6 intermediate and ultrarapid metabolizer phenotypes
Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites—a study in 839 patients with known CYP2D6 genotype
Bedeutung des CYP2D6-Genpolymorphismus für die Therapiesicherheit und Wirksamkeit von CYP2D6-abhängig metabolisierten Antidepressiva
Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivo
Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions
Allele Drop Out Conferred by a Frequent CYP2D6 Genetic Variation For Commonly Used CYP2D6*3 Genotyping Assays
Enantioselective metabolism of primaquine by human CYP2D6
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
The CYP2D6 animal model: how to induce autoimmune hepatitis in mice
CYP2D6-Phänotypisierung und Bestimmung des Dextromethorphanmetabolismus mittels Hochleistungsflüssigkeitschromatographie
Frequencies of CYP2D6 genetic polymorphisms in Arab populations
CYP2D6-Phänotypisierung und Bestimmung des Dextromethorphanmetabolismus mittels Hochleistungsflüssigkeitschromatographie
Molecular analysis of mechanisms leading to CYP2D6 intermediate and ultrarapid metabolizer phenotypes